Detalles de la búsqueda
1.
Available oral lipid-lowering agents could bring most high-risk patients to target: an estimate based on the Dyslipidemia International Study II-Italy.
J Cardiovasc Med (Hagerstown)
; 19(9): 485-490, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29917002
2.
Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
J Med Chem
; 46(18): 3853-64, 2003 Aug 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-12930147
Resultados
1 -
2
de 2
1
Próxima >
>>